• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

7',5'-α-双环 DNA:用于寡核苷酸外显子剪接调节治疗的新化学。

7',5'-alpha-bicyclo-DNA: new chemistry for oligonucleotide exon splicing modulation therapy.

机构信息

Alpha Anomeric, 140 Bis, Rue de Rennes, 75006 Paris, France.

Department of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

出版信息

Nucleic Acids Res. 2021 Dec 2;49(21):12089-12105. doi: 10.1093/nar/gkab1097.

DOI:10.1093/nar/gkab1097
PMID:34850138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8643641/
Abstract

Antisense oligonucleotides are small pieces of modified DNA or RNA, which offer therapeutic potential for many diseases. We report on the synthesis of 7',5'-α-bc-DNA phosphoramidite building blocks, bearing the A, G, T and MeC nucleobases. Solid-phase synthesis was performed to construct five oligodeoxyribonucleotides containing modified thymidine residues, as well as five fully modified oligonucleotides. Incorporations of the modification inside natural duplexes resulted in strong destabilizing effects. However, fully modified strands formed very stable duplexes with parallel RNA complements. In its own series, 7',5'-α-bc-DNA formed duplexes with a surprising high thermal stability. CD spectroscopy and extensive molecular modeling indicated the adoption by the homo-duplex of a ladder-like structure, while hetero-duplexes with DNA or RNA still form helical structure. The biological properties of this new modification were investigated in animal models for Duchenne muscular dystrophy and spinal muscular atrophy, where exon splicing modulation can restore production of functional proteins. It was found that the 7',5'-α-bc-DNA scaffold confers a high biostability and a good exon splicing modulation activity in vitro and in vivo.

摘要

反义寡核苷酸是经过修饰的 DNA 或 RNA 片段,具有治疗多种疾病的潜力。我们报告了 7',5'-α-bc-DNA 膦酰胺亚单位构建块的合成,其带有 A、G、T 和 MeC 碱基。通过固相合成构建了包含修饰的胸苷残基的五个寡脱氧核苷酸,以及五个完全修饰的寡核苷酸。修饰物在天然双链体中的掺入导致强烈的不稳定效应。然而,完全修饰的链与平行的 RNA 互补物形成非常稳定的双链体。在其自身系列中,7',5'-α-bc-DNA 形成具有惊人高热稳定性的双链体。CD 光谱和广泛的分子建模表明,同型双链体采用梯状结构,而与 DNA 或 RNA 的异型双链体仍形成螺旋结构。该新修饰的生物学特性在杜氏肌营养不良症和脊髓性肌萎缩症的动物模型中进行了研究,其中外显子剪接调节可以恢复功能性蛋白质的产生。结果发现,7',5'-α-bc-DNA 支架在体外和体内均具有高生物稳定性和良好的外显子剪接调节活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/34d941da4297/gkab1097fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/f45a872b3b3b/gkab1097gra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/56c195a426ea/gkab1097fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/00b7ed6c5d1d/gkab1097fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/f2c9f7f9a182/gkab1097fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/ee2e172665c1/gkab1097fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/15411bb19b46/gkab1097fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/338071c4bd86/gkab1097fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/bcfe8766ca93/gkab1097fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/6cc3717e5a43/gkab1097fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/b011fb503cc7/gkab1097fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/e9775e606ae5/gkab1097fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/d458b8869d3a/gkab1097fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/4dce0d908d0d/gkab1097fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/34d941da4297/gkab1097fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/f45a872b3b3b/gkab1097gra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/56c195a426ea/gkab1097fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/00b7ed6c5d1d/gkab1097fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/f2c9f7f9a182/gkab1097fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/ee2e172665c1/gkab1097fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/15411bb19b46/gkab1097fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/338071c4bd86/gkab1097fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/bcfe8766ca93/gkab1097fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/6cc3717e5a43/gkab1097fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/b011fb503cc7/gkab1097fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/e9775e606ae5/gkab1097fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/d458b8869d3a/gkab1097fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/4dce0d908d0d/gkab1097fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/8643641/34d941da4297/gkab1097fig13.jpg

相似文献

1
7',5'-alpha-bicyclo-DNA: new chemistry for oligonucleotide exon splicing modulation therapy.7',5'-α-双环 DNA:用于寡核苷酸外显子剪接调节治疗的新化学。
Nucleic Acids Res. 2021 Dec 2;49(21):12089-12105. doi: 10.1093/nar/gkab1097.
2
Designing Effective Antisense Oligonucleotides for Exon Skipping.设计用于外显子跳跃的有效反义寡核苷酸
Methods Mol Biol. 2018;1687:143-155. doi: 10.1007/978-1-4939-7374-3_10.
3
New developments in exon skipping and splice modulation therapies for neuromuscular diseases.神经肌肉疾病中外显子跳跃和剪接调控治疗的新进展。
Expert Opin Biol Ther. 2014 Jun;14(6):809-19. doi: 10.1517/14712598.2014.896335. Epub 2014 Mar 12.
4
Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro.体外系统评价 2'-氟修饰嵌合反义寡核苷酸介导的外显子跳跃。
Sci Rep. 2019 Apr 15;9(1):6078. doi: 10.1038/s41598-019-42523-0.
5
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle.遗传性神经肌肉疾病:治疗革命时代的生活。第 2 部分:运动神经元和骨骼肌疾病。
Neurol Sci. 2019 Apr;40(4):671-681. doi: 10.1007/s10072-019-03764-z. Epub 2019 Feb 25.
6
Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubes.短链(16聚体)锁核酸剪接转换寡核苷酸可恢复杜氏肌营养不良症肌管中的抗肌萎缩蛋白生成。
PLoS One. 2017 Jul 24;12(7):e0181065. doi: 10.1371/journal.pone.0181065. eCollection 2017.
7
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.基于反义寡核苷酸的神经肌肉疾病治疗
Molecules. 2017 Apr 5;22(4):563. doi: 10.3390/molecules22040563.
8
Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.设计用于外显子跳跃和外显子包含的有效剪接转换反义寡核苷酸的技巧。
Methods Mol Biol. 2018;1828:79-90. doi: 10.1007/978-1-4939-8651-4_5.
9
RNA-targeted splice-correction therapy for neuromuscular disease.针对神经肌肉疾病的 RNA 靶向剪接校正治疗。
Brain. 2010 Apr;133(Pt 4):957-72. doi: 10.1093/brain/awq002. Epub 2010 Feb 11.
10
Screening for antisense modulation of dystrophin pre-mRNA splicing.肌营养不良蛋白前体信使核糖核酸剪接的反义调节筛选
Neuromuscul Disord. 2002 Oct;12 Suppl 1:S67-70. doi: 10.1016/s0960-8966(02)00085-8.

引用本文的文献

1
Introduction to the themed collection in honour of Professor Christian Leumann.纪念克里斯蒂安·勒曼教授主题文集引言。
RSC Med Chem. 2024 Oct 22;15(11):3636-8. doi: 10.1039/d4md90039a.
2
A Visual Compendium of Principal Modifications within the Nucleic Acid Sugar Phosphate Backbone.核酸糖磷酸骨架主要修饰的直观纲要。
Molecules. 2024 Jun 26;29(13):3025. doi: 10.3390/molecules29133025.
3
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases.剪接调节反义寡核苷酸作为遗传性代谢疾病的治疗方法。

本文引用的文献

1
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
2
Opportunities and challenges for antisense oligonucleotide therapies.反义寡核苷酸疗法的机遇与挑战。
J Inherit Metab Dis. 2021 Jan;44(1):72-87. doi: 10.1002/jimd.12251. Epub 2020 Jun 3.
3
Phosphorothioate modified oligonucleotide-protein interactions.硫代磷酸酯修饰的寡核苷酸-蛋白质相互作用。
BioDrugs. 2024 Mar;38(2):177-203. doi: 10.1007/s40259-024-00644-7. Epub 2024 Jan 22.
4
Evaluation of Chemically Modified Nucleic Acid Analogues for Splice Switching Application.用于剪接转换应用的化学修饰核酸类似物的评估。
ACS Omega. 2023 Dec 11;8(51):48650-48661. doi: 10.1021/acsomega.3c07618. eCollection 2023 Dec 26.
5
Amplifying gene expression with RNA-targeted therapeutics.利用 RNA 靶向治疗技术增强基因表达。
Nat Rev Drug Discov. 2023 Jul;22(7):539-561. doi: 10.1038/s41573-023-00704-7. Epub 2023 May 30.
Nucleic Acids Res. 2020 Jun 4;48(10):5235-5253. doi: 10.1093/nar/gkaa299.
4
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.对 PS-ASO 治疗药物进行化学修饰可降低细胞内蛋白质结合,提高治疗指数。
Nat Biotechnol. 2019 Jun;37(6):640-650. doi: 10.1038/s41587-019-0106-2. Epub 2019 Apr 29.
5
Evaluation of the effect of 2'-O-methyl, fluoro hexitol, bicyclo and Morpholino nucleic acid modifications on potency of GalNAc conjugated antisense oligonucleotides in mice.评估2'-O-甲基、氟己糖醇、双环和吗啉代核酸修饰对GalNAc缀合反义寡核苷酸在小鼠体内效力的影响。
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3774-3779. doi: 10.1016/j.bmcl.2018.10.011. Epub 2018 Oct 10.
6
Palmitoylated phosphodiester gapmer designs with albumin binding capacity and maintained in vitro gene silencing activity.具有白蛋白结合能力并保持体外基因沉默活性的棕榈酰化磷酸二酯键间隔聚合物设计。
J Gene Med. 2018 Jul;20(7-8):e3025. doi: 10.1002/jgm.3025. Epub 2018 Jun 25.
7
Cyclic Peptides to Improve Delivery and Exon Skipping of Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy.环状肽可改善肌营养不良症小鼠模型中反义寡核苷酸的传递和外显子跳跃。
Mol Ther. 2018 Jan 3;26(1):132-147. doi: 10.1016/j.ymthe.2017.10.004. Epub 2017 Oct 12.
8
Locked nucleic acid: modality, diversity, and drug discovery.锁核酸:模式、多样性与药物发现。
Drug Discov Today. 2018 Jan;23(1):101-114. doi: 10.1016/j.drudis.2017.09.018. Epub 2017 Oct 6.
9
Probing the Backbone Topology of DNA: Synthesis and Properties of 7',5'-Bicyclo-DNA.探索DNA的骨架拓扑结构:7',5'-双环DNA的合成与性质
Chemistry. 2017 Jun 12;23(33):7953-7968. doi: 10.1002/chem.201700435. Epub 2017 Apr 10.
10
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.杜氏肌营养不良症的动物模型:从基本机制到基因治疗
Dis Model Mech. 2015 Mar;8(3):195-213. doi: 10.1242/dmm.018424.